The initiative will leverage IU’s seven state campuses, as well as partnerships with state officials, Indianapolis-based IU Health and Eskenazi Health, among others, to ease the burden of drug overdose deaths in the state. The program will be one of the largest state-based initiatives to address the opioid epidemic and the largest such program spearheaded by a university.
“Through this vitally important initiative, Indiana University will bring to bear its formidable and extensive clinical and research capabilities, large statewide footprint in medicine and healthcare, and powerful community and industry partnerships to achieve maximum impact toward the goal of more effectively treating patients and implementing preventative substance abuse programs,” said Michael McRobbie, PhD, Indiana University president.
More articles on opioids:
7 things to know about the history and science behind opioid addiction
Study: Medicare places few prescribing restrictions on opioids
Physicians with low quality ratings prescribe more opioids, barbiturates for headaches
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
